Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Matrix metal proteinase-2 polypeptide inhibitors and application thereof

A peptide inhibitor and matrix metal technology, applied in the field of matrix metalloproteinase-2 peptides, can solve the problems of side effects, lack of specificity of small molecule inhibitors, etc.

Active Publication Date: 2014-09-03
NANTONG GUANGTAI BIOCHEM PROD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation and use of macromolecular inhibitors has limited their development, for example recombinant human matrix proteinase tissue inhibitor of metalloproteinase-3 has an in vivo half-life of only 4 minutes
Many successful small molecule inhibitors, such as Marimastat, can inhibit the activity of matrix metalloproteinases at the nanomolar level, but small molecule inhibitors lack specificity. produce side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Matrix metal proteinase-2 polypeptide inhibitors and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] Chemical Synthesis of Peptides

[0018] The peptides were synthesized using Fmoc chemistry. The synthesis reaction proceeds from the C-terminus to the N-terminus. There are free amino groups on the Rink medium (available from Advanced ChemTech), and Thr, His, Ser, Phe, Asn and Asp are connected sequentially. During each ligation step, the amino acid residues are activated, and the activation mixture contains 4 times as many HBTU, HOBt, DIEA and Fmoc-amino acids as there are free amino groups on the medium. After each amino acid linking reaction, a mixture of pyridine / acetic acid / N-methylimidazole (4:1:0.5) was used to block unlinked free amino groups for 10 min. After each amino acid ligation reaction and before the next amino acid is ligated, the Fmoc-group on the medium must be removed, and the Fmoc-group is removed using dimethylformamide containing 20% ​​piperidine, which takes 15 minutes. Finally, after all amino acid residues are linked sequentially, the peptide...

Embodiment 2

[0022] IC50 values ​​of polypeptide inhibitors against several target enzymes in vitro: matrix metalloproteinase-3, -8, -2 and tumor necrosis factor releasing enzyme (both purchased from sigma company).

[0023] Recombinant human matrix metalloproteinase-2 was expressed by E. coli cells. The enzyme was activated with 0.01 μM matrix metalloproteinase-3 active site in 100 mM Tris / HCl, pH 7.4, 100 mM NaCl, 10 mM CaCl 2 and 0.01% Tween-20. The concentration of MMP-2 upon activation was 72 ng / μl (1 μM). Enzyme activity is detected by cleaving the fluorescently generated peptide substrate Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH 2 And detect the generated fluorescence value (excitation wavelength=328 nm, detection wavelength=392 nm). All detections were carried out in 100 μl reaction system at 37°C. The measured IC50 value was 42.99 μmol.

[0024] Recombinant human matrix metalloproteinase-8 is detected similarly to that of -2 and uses the same fluorogenic substrate. Reactions were...

Embodiment 3

[0028] Testing the Viability of Peptide Inhibitors in Vivo Using an Endotoxic Shock Model

[0029] Before establishing the endotoxic shock model, we first determined the LD50 of LPS (E. coli 0111: B4) mice to be 50 μg per mouse, and we used 100 μg per mouse in the experiment, so that the control group All mice died. A positive control experiment was done with Regasepin2. The mice in the control group were injected with 100 μg of LPS, while the mice in the Regasepin2 experimental group were injected with 0.7 mg of polypeptide 5 minutes after LPS injection. By making a Kaplan-Meier survival curve, it was found that Regasepin2 can effectively protect mice injected with 100 μg and improve the survival rate. After the endotoxin shock model was successfully established in mice, the model was used to detect the in vivo activity of Asp-Asn-Phe-Ser-His-Thr. The mice in the control group (12) were injected with 100 μg of LPS, while the mice in the polypeptide inhibitor group (12) were ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Matrix metalloproteinase-2 polypeptide inhibitors and applications thereof. The invention relates to the field of medicine, in particular to a polypeptide capable of inhibiting matrix metalloproteinase-2 and tumor necrosis factor-releasing enzyme and reducing acute inflammatory response damage to the body. Its sequence is Asp-Asn-Phe-Ser-His-Thr, which is a brand new sequence. They can inhibit the activity of matrix metalloproteinase-2 and tumor necrosis factor releasing enzyme in vitro at the level of 1 micromolar, and increase the activity of endogenous enzymes in vivo. The survival rate of mice in toxin shock has potential value for new drug development.

Description

technical field [0001] The invention relates to a matrix metalloproteinase-2 polypeptide and its application, in particular to a polypeptide capable of inhibiting matrix metalloproteinase-2 and reducing acute inflammatory response damage to the body. Background technique [0002] Sepsis has always been a serious medical problem. Early sepsis without timely and effective treatment can progress to severe sepsis and septic shock, with mortality rates of 20%-30% and 40%-70%, respectively. The medical field has been researching effective treatment methods, such as early symptomatic treatment, activated protein C, corticosteroid treatment and so on. In recent years, with the deepening of medical research, great progress has been made in the understanding and treatment of sepsis. Among them, matrix metalloproteinase-2 (MMP-2) plays an important role in endotoxin shock. [0003] Matrix metalloproteinases are a group of more than 20 structurally similar and functionally related e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06A61K38/08A61P29/00
Inventor 李春涛
Owner NANTONG GUANGTAI BIOCHEM PROD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com